Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "Cardiovascular Disease Monitoring and Diagnostic Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Cardiovascular Disease Monitoring and Diagnostic Devices Market to Reach $3.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.
ECG Systems, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Holter Monitors segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $592.1 Million, While China is Forecast to Grow at 9.3% CAGR
The Cardiovascular Disease Monitoring and Diagnostic Devices market in the U.S. is estimated at US$592.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$706.9 Million by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Implantable Loop Recorders Segment to Record 7.4% CAGR
In the global Implantable Loop Recorders segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$82.9 Million in the year 2020 will reach a projected size of US$131.6 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447.5 Million by the year 2027, while Latin America will expand at a 8.7% CAGR through the analysis period.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Cardiovascular Diseases: Facts & Figures
Recent Market Activity
CVD Monitoring and Diagnostic Devices on a High Growth Trajectory
The US Dominates, Asia-Pacific to Witness Fastest Growth
ECG Systems Lead the CVD Diagnostics and Monitoring Market
Holter Monitoring Systems: An Established Market, Facing Threats
Ambulatory Cardiac Monitoring Devices - A Comparison of Holter and Other Devices
Evolution of Cardiac Monitoring Devices
A Comparison of Key Features of Three Major Ambulatory ECG Systems- Holter Monitoring, Event Monitoring and MCOT
Benefits and Drawbacks of Three Major Primary Cardiac Event Monitoring Systems - Holter Monitoring, Event Monitoring and MCOT
Implantable Loop Recorder (ILR) to Register the Fastest Growth
ECG Management Systems: Integral for Data Storage
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 60 Featured)
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
GE Healthcare UK Ltd.
Koninklijke Philips N.V
Mortara Instrument Inc.
Nihon Kohden Corporation
Spacelabs Healthcare Inc.
St. Jude Medical Inc.
3. MARKET TRENDS & DRIVERS
Global Menace of Cardiovascular Disease (CVD) - A Major Growth Driver
Aging Population Drives Demand
Increase in Healthcare Spending Bodes Well for Cardiac Monitoring Market
Risk of CAD in Obesity Offers Prospects for Cardiac Monitoring Devices
Diabetics at Higher Risk of Heart Diseases
Increasing Preference for Homecare Drives Cardiac Monitoring Devices Demand
SELECT PRODUCT TRENDS/ADVANCEMENTS
Holter Devices Continue to Witness Technological Advances
Disposable Devices - the New Trend in Holter Monitors
ZIO Wireless Patch Holter Monitors
Mobile Cardiac Telemetry (MCT): A Potential Threat to Holter Monitors
Remote Monitoring Reduces Hospital Admissions and Readmissions
Innovations in Remote ECG Monitoring
Advancements in ECG Management Systems
GE Muse Version 9 ECG Management System
Mobile Access for ECG Waveforms
Others Advancements in ECG Management Systems
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Rest Of Europe
Rest Of Asia-Pacific
Rest Of Latin America
United Arab Emirates
Rest Of Middle East
Total Companies Profiled: 60
For more information about this report visit https://www.researchandmarkets.com/r/7bn3j1
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900